Literature DB >> 9700765

The corticotrophin-releasing factor-binding protein: an act of several parts.

C F Kemp1, R J Woods, P J Lowry.   

Abstract

Previously the function of hormone binding proteins has been viewed entirely as one of either sequestering ligand activity or of delivering ligand to target tissues. However, some binding proteins have the ability when complexed with ligand to interact directly with target tissues and can undergo considerable post-translational and post-secretional modifications that serve to modify their action. We propose that for the corticotrophin-releasing factor-binding protein (CRF-BP), this adds a further level at which hormonal action may be regulated. This contrasts with previous concepts of a passive role and shows them as important regulators of hormonal action in their own right.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700765     DOI: 10.1016/s0196-9781(98)00057-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  Timing of prenatal exposure to trauma and altered placental expressions of hypothalamic-pituitary-adrenal axis genes and genes driving neurodevelopment.

Authors:  W Zhang; Q Li; M Deyssenroth; L Lambertini; J Finik; J Ham; Y Huang; K J Tsuchiya; P Pehme; J Buthmann; S Yoshida; J Chen; Y Nomura
Journal:  J Neuroendocrinol       Date:  2018-04       Impact factor: 3.627

Review 2.  The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?

Authors:  Carolina L Haass-Koffler
Journal:  Alcohol       Date:  2017-10-13       Impact factor: 2.405

Review 3.  Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.

Authors:  Cynthia L Bethea; Fernanda B Lima; Maria L Centeno; Karin V Weissheimer; Olga Senashova; Arubala P Reddy; Judy L Cameron
Journal:  J Chem Neuroanat       Date:  2011-06-06       Impact factor: 3.052

4.  Ovarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaques.

Authors:  R L Sanchez; A P Reddy; C L Bethea
Journal:  Neuroscience       Date:  2010-09-15       Impact factor: 3.590

5.  A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.

Authors:  K Eckart; O Jahn; J Radulovic; H Tezval; L van Werven; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 6.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

7.  Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1.

Authors:  Mark O Huising; Joan M Vaughan; Shaili H Shah; Katherine L Grillot; Cynthia J Donaldson; Jean Rivier; Gert Flik; Wylie W Vale
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

8.  Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons.

Authors:  Hui-Ling Wang; Marisela Morales
Journal:  J Comp Neurol       Date:  2008-07-20       Impact factor: 3.215

9.  CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface.

Authors:  Paula G Slater; Cledi A Cerda; Luis A Pereira; María E Andrés; Katia Gysling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

10.  Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice.

Authors:  Lucas Albrechet-Souza; Lara S Hwa; Xiao Han; Eric Y Zhang; Joseph F DeBold; Klaus A Miczek
Journal:  Alcohol Clin Exp Res       Date:  2015-08-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.